Otizm spektrum bozukluğu ve DEHB tanılarıyla izlenen bir çocukta metilfenidat ile ortaya çıkan görsel varsanılar: Olgu sunumu

Otizm spektrum bozukluğu (OSB) olan çocuklar sıklıkla dikkat eksikliği hiperaktivite bozukluğu (DEHB) belirtileri gösterirler. Metilfenidat (MPH) OSB'li çocuklarda DEHB belirtileri için sık kullanılmaktadır. Bununla birlikte bu çocukların MPH'nin yan etkilerine daha duyarlı oldukları bildirilmiştir. MPH'nin en sık görülen yan etkileri uykusuzluk, iştahsızlık, bulantı, kusma, baş ağrısı ve karın ağrısıdır. Görsel varsanılar MPH tedavisi sırasında nadiren görülmektedir. Bu yazıda, hızlı salınımlı MPH tedavisi sırasında görsel varsanılar gelişen OSB'li 10 yaşında bir erkek olgu sunuyoruz. MPH, özellikle komorbid OSB ve DEHB varlığında psikotik belirtilere neden olabilir. Klinisyenler bu gibi komorbid durumlarda bu nadir yan etkinin farkında olmalıdırlar.

Methylphenidate-induced visual hallucinations in a child with autism spectrum disorder and ADHD: a case report

Children with autism spectrum disorder (ASD) often exhibit the symptoms of attention-deficit/hyperactivity disorder (ADHD). Methylphenidate (MPH) is commonly used for ADHD symptoms in children with ASD. However, these children are reported to be more sensitive to side effects of MPH. The most common side effects of MPH are insomnia, decreased appetite, nausea, vomiting, headache, and abdominal pain. Visual hallucinations are rarely seen during MPH treatment. In this paper, we report a 10-year-old male patient with ASD who presented with visual hallucinations during treatment with immediate-release MPH. MPH can cause psychotic symptoms especially in the presence of comorbid ASD and ADHD. Clinicians should be aware of this rare side effect in such comorbid cases.

PDF

___

1. Wilens T, Pelham W, Stein M, Conners CK, Abikoff H, Atkins M, et al. ADHD treatment with oncedaily OROS methylphenidate: interim 12-month results from a long-term open-label study. J Am Acad Child Adolesc Psychiatry 2003; 42:424-433.

2. Leyfer OT, Folstein SE, Bacalman S, Davis NO, Dinh E, Morgan J, et al. Comorbid psychiatric disorders in children with autism: interview development and rates of disorders. J Autism Dev Disord 2006; 36:849-861.

3. Miller NL, Findling RL. Is methylphenidate a safe and effective treatment for ADHD-like symptoms in children with pervasive developmental disorders? Expert Opin Pharmacother 2007; 8:1025- 1028.

4. Cummings JL, Miller BL. Visual hallucination. Clinical occurrence and use in differential diagnosis. West J Med 1987; 146:46-51.

5. Halevy A, Shuper A. Methylphenidate induction of complex visual hallucinations. J Child Neurol 2009; 24:1005-1007.

6. Porfirio MC, Giana G, Giovinazzo S, Curatolo P. Methylphenidate-induced visual hallucinations. Neuropediatrics 2011; 42:30-31.

7. Gross-Tzur V, Joseph A, Shalev RS. Hallucinations during methylphenidate therapy. Neurology 2004; 63:753-754.

8. Ross R. Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder. Am J Psychiatry 2006; 163:1149- 1152.

9. Ercan ES, Mukaddes NM, Yazgan Y, Akay AP, Gündoğdu ÖY. Dikkat eksikliği hiperaktivite bozukluğu. Akay AP, Ercan ES, Perçinel İ, Ardıç ÜA, Demirkaya SK, Güler AS (Ed.), Çocuk ve Ergen Ruh Sağlığı ve Hastalıkları, second ed., Ankara: HYB Basım Yayın, 2016, p.33-55.

10. Abali O, Mukaddes NM. Methylphenidate induced hallucinations: case report. Bulletin of Clinical Psychopharmacology 2007; 17:195-197.

11. Chertand E, Fitzpatrick R. Psychotic side effects of psychostimulants: a 5-year review. Can J Psychiatry 1999; 44:811-813.

12. Rashid J, Mitelman S. Methylphenidate and somatic hallucinations. J Am Acad Child Adolesc Psychiatry 2007; 46:945-946.

13. Zhao Y, Kerscher N, Eysel U, Funke K. D1 and D2 receptor-mediated dopaminergic modulation of visual responses in cat dorsal lateral geniculate nucleus. J Physiology 2002; 539:223-238.

14. Ekinci O, Toros F. Psychostimulant toxicity in children. Archives Medical Review Journal 2013; 22:184-193.

15. Ghuman JK, Aman MG, Lecavalier L, Riddle MA, Gelenberg, A, Wright R, et al. Randomized, placebo-controlled, cross-over study of methylphenidate for attention-deficit/hyperactivity disorder symptoms in preschoolers with developmental disorders. J Child Adolesc Psychopharmacol 2009; 19:329-339.